Background The combined technique is the preferred technique for sentinel lymph node
biopsy (SLNB) but blue dye and radioisotope both have significant drawbacks including …

Abstract Background The SentiMAG Multicentre Trial evaluated a new magnetic technique
for sentinel lymph node biopsy (SLNB) against the standard (radioisotope and blue dye or …

Background and Objectives The French Sentimag feasibility trial evaluated a new method
for the localization of breast cancer sentinel lymph node (SLN) using Sienna+® …

Background Some hospitals lack facilities for radioisotopes in sentinel node biopsy. A novel
method is used with a superparamagnetic tracer and a magnetometer instead of a …

Aims The gold standard for detection of Sentinel Lymph Nodes (SLN) is a combined
radioisotope and blue dye breast injection, using a gamma probe (GP). A new, non …

The magnetic technique for sentinel node biopsy provides a radioisotope-free alternative for
staging breast cancer. It requires refinement to reduce “residual iron content” at injection …

Background: Primary tumour biology and axillary lymph node status are crucial prognostic
factors in breast cancer treatment. The LowMag trial introduced a magnetic sentinel lymph …

The gold standard technique of Sentinel Lymph Node Biopsy (SLNB) is the dual technique
of radioactive tracer with blue dye. The aim of this study was to assess the node …

Background: The SentiMAG Multicentre Trial, an international phase II paired equivalence
trial, evaluated a new magnetic technique for sentinel node biopsy (SLNB) against the …

Background Sentinel lymph node biopsy (SLNB) is a highly accurate method for staging the
axilla in early breast cancer. Superparamagnetic iron oxide mapping agents have been …